Background: Current guidelines for Helicobacter pylori eradication recommen
d 7 days of a proton-pump inhibitor, clarithromycin (C), and either metroni
dazole (M) or amoxycillin (A). A shorter course would be cheaper and could
be as effective.
Aim: This study was designed to investigate the efficacy of three 5-day reg
imens based on lansoprazole (L).
Methods: 168 dyspepsia patients with H. pylori infection were randomized to
receive a 5-day course of either LCM, LAC or CALM, and a C-13-urea breath
test was performed after 4 weeks to assess eradication.
Results: 160 patients completed the study. Intention-to-treat eradication r
ates were as follows: LCM 81%, LAC 59%, CALM 88%, LCM and CALM gave signifi
cantly better eradication rates than LAC. There was no significant differen
ce in adverse events across the three groups. Logistical regression analysi
s showed that the specific regimen used and the age of the patient were the
only factors influencing eradication outcome.
Conclusions: Five days of CALM yields acceptable eradication rates, and is
cheaper than conventional 7-day proton pump inhibitor-triple therapy. It ap
pears to offer good results in metronidazole-resistant strains of H. pylori
. A randomized trial comparing 5-day CALM with conventional 7-day therapy i
s needed before this regimen can be recommended for routine use.